OpenBiome Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OpenBiome's estimated annual revenue is currently $5.1M per year.(i)
  • OpenBiome's estimated revenue per employee is $155,000

Employee Data

  • OpenBiome has 33 Employees.(i)
  • OpenBiome grew their employee count by -3% last year.

OpenBiome's People

NameTitleEmail/Phone
1
Co-founder and AdvisorReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Director Clinical OutreachReveal Email/Phone
4
Director External AffairsReveal Email/Phone
5
Human Capital ManagerReveal Email/Phone
6
Regulatory Affairs ManagerReveal Email/Phone
7
Manager Legal AffairsReveal Email/Phone
8
Accounting ManagerReveal Email/Phone
9
Site SupervisorReveal Email/Phone
10
Manufacturing Technician IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is OpenBiome?

OpenBiome's mission is to expand access to fecal microbiota transplantations (FMT) and help lead groundbreaking research into the human microbiome. We care deeply about helping patients. We get excited about poop. We are passionate individuals who get up in the morning to help our clinical partners and strive to be at the cutting edge of a new field of medical science that we are helping to build.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OpenBiome News

2022-04-17 - Finch Therapeutics to shed 20% of its workforce

In January 2021, Finch's then-contract manufacturer, OpenBiome, was released from clinical hold after implementing a direct testing method for...

2022-04-17 - Fitch Therapeutics to shed 20% of its workforce

At that time, the FDA placed Finch's IND for CP101 and the IND of its then-contract manufacturer, OpenBiome, on partial clinical hold,...

2021-02-23 - OpenBiome to wind down stool bank operations

OpenBiome, the nation’s first public stool bank, will soon end its program for collecting, screening, and shipping material for fecal microbiota transplants, or FMT, the company announced Tuesday. It won’t be immediate; the company plans to resume shipping the stool it has in its inventory to p ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M33N/AN/A
#2
N/A333%N/A
#3
$8.5M333%N/A
#4
$2.7M33-8%N/A
#5
$3.7M330%N/A